Profile | GDS5420 / 204347_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 287.78 | 58 |
GSM1296119 | B_lesional_pre-dose | 470.66 | 67 |
GSM1296076 | C_lesional_pre-dose | 471.96 | 68 |
GSM1296092 | D_lesional_pre-dose | 527.58 | 69 |
GSM1296103 | E_lesional_pre-dose | 377.75 | 63 |
GSM1296078 | F_lesional_pre-dose | 384.2 | 65 |
GSM1296107 | G_lesional_pre-dose | 507.74 | 68 |
GSM1296109 | H_lesional_pre-dose | 322.11 | 59 |
GSM1296080 | I_lesional_pre-dose | 320.55 | 61 |
GSM1296090 | J_lesional_pre-dose | 454.45 | 67 |
GSM1296074 | K_lesional_pre-dose | 459.43 | 67 |
GSM1296111 | L_lesional_pre-dose | 414.51 | 64 |
GSM1296099 | M_lesional_pre-dose | 330.82 | 60 |
GSM1296086 | O_lesional_pre-dose | 450.62 | 67 |
GSM1296117 | P_lesional_pre-dose | 530.04 | 69 |
GSM1296113 | Q_lesional_pre-dose | 562.83 | 70 |
GSM1296096 | R_lesional_pre-dose | 420.59 | 65 |
GSM1296105 | S_lesional_pre-dose | 274.12 | 57 |
GSM1296098 | T_lesional_pre-dose | 287.08 | 58 |
GSM1296101 | U_lesional_pre-dose | 295.62 | 58 |
GSM1296121 | V_lesional_pre-dose | 383.35 | 63 |
GSM1296088 | W_lesional_pre-dose | 288.4 | 59 |
GSM1296082 | X_lesional_pre-dose | 519.18 | 69 |
GSM1296115 | Y_lesional_pre-dose | 569.89 | 70 |
GSM1296084 | Z_lesional_pre-dose | 187.26 | 51 |
GSM1296072 | B_lesional_day8 | 412.54 | 64 |
GSM1296069 | L_lesional_day8 | 373.79 | 62 |
GSM1296071 | P_lesional_day8 | 352.88 | 61 |
GSM1296070 | Y_lesional_day8 | 403.38 | 63 |
GSM1296073 | V_lesional_day8 | 446.04 | 66 |
GSM1296034 | A_lesional_day15 | 108.25 | 41 |
GSM1296041 | G_lesional_day15 | 647.68 | 72 |
GSM1296035 | R_lesional_day15 | 319.45 | 60 |
GSM1296038 | U_lesional_day15 | 363.04 | 62 |
GSM1296047 | B_lesional_day15 | 370.89 | 62 |
GSM1296039 | E_lesional_day15 | 377.13 | 63 |
GSM1296042 | H_lesional_day15 | 322.51 | 60 |
GSM1296043 | L_lesional_day15 | 323.85 | 59 |
GSM1296037 | M_lesional_day15 | 257.86 | 56 |
GSM1296046 | P_lesional_day15 | 520.74 | 68 |
GSM1296044 | Q_lesional_day15 | 594.22 | 70 |
GSM1296045 | Y_lesional_day15 | 438.71 | 65 |
GSM1296025 | C_lesional_day15 | 165.46 | 50 |
GSM1296033 | D_lesional_day15 | 329.14 | 60 |
GSM1296027 | I_lesional_day15 | 338.54 | 62 |
GSM1296032 | J_lesional_day15 | 208.84 | 53 |
GSM1296024 | K_lesional_day15 | 173.75 | 51 |
GSM1296031 | W_lesional_day15 | 126.02 | 44 |
GSM1296028 | X_lesional_day15 | 400.54 | 64 |
GSM1296029 | Z_lesional_day15 | 215.34 | 54 |
GSM1296026 | F_lesional_day15 | 234.35 | 56 |
GSM1296030 | O_lesional_day15 | 358.48 | 63 |
GSM1296040 | S_lesional_day15 | 346.26 | 61 |
GSM1296036 | T_lesional_day15 | 231.9 | 54 |
GSM1296048 | V_lesional_day15 | 376.22 | 63 |
GSM1296059 | A_lesional_day43 | 440.42 | 65 |
GSM1296066 | G_lesional_day43 | 478.43 | 67 |
GSM1296060 | R_lesional_day43 | 292.56 | 58 |
GSM1296063 | U_lesional_day43 | 465.69 | 67 |
GSM1296064 | E_lesional_day43 | 416.46 | 65 |
GSM1296067 | H_lesional_day43 | 251.61 | 55 |
GSM1296062 | M_lesional_day43 | 298.23 | 58 |
GSM1296068 | Q_lesional_day43 | 471.97 | 66 |
GSM1296050 | C_lesional_day43 | 243.76 | 56 |
GSM1296057 | D_lesional_day43 | 281.03 | 58 |
GSM1296052 | I_lesional_day43 | 378.4 | 63 |
GSM1296054 | J_lesional_day43 | 170.77 | 49 |
GSM1296049 | K_lesional_day43 | 169.07 | 50 |
GSM1296055 | W_lesional_day43 | 209.31 | 52 |
GSM1296053 | X_lesional_day43 | 155.74 | 48 |
GSM1296058 | Z_lesional_day43 | 267.18 | 57 |
GSM1296051 | F_lesional_day43 | 253.8 | 57 |
GSM1296056 | O_lesional_day43 | 392.11 | 64 |
GSM1296065 | S_lesional_day43 | 478.47 | 67 |
GSM1296061 | T_lesional_day43 | 233.68 | 54 |
GSM1296095 | A_non-lesional_pre-dose | 543.24 | 69 |
GSM1296120 | B_non-lesional_pre-dose | 453.28 | 66 |
GSM1296077 | C_non-lesional_pre-dose | 280.18 | 58 |
GSM1296093 | D_non-lesional_pre-dose | 120.68 | 43 |
GSM1296104 | E_non-lesional_pre-dose | 368.83 | 63 |
GSM1296079 | F_non-lesional_pre-dose | 197.33 | 53 |
GSM1296108 | G_non-lesional_pre-dose | 503.2 | 68 |
GSM1296110 | H_non-lesional_pre-dose | 372.91 | 61 |
GSM1296081 | I_non-lesional_pre-dose | 167.03 | 51 |
GSM1296091 | J_non-lesional_pre-dose | 454.54 | 66 |
GSM1296075 | K_non-lesional_pre-dose | 399.19 | 65 |
GSM1296112 | L_non-lesional_pre-dose | 330.78 | 59 |
GSM1296100 | M_non-lesional_pre-dose | 308.41 | 59 |
GSM1296087 | O_non-lesional_pre-dose | 386.42 | 64 |
GSM1296118 | P_non-lesional_pre-dose | 344.92 | 60 |
GSM1296114 | Q_non-lesional_pre-dose | 545.21 | 69 |
GSM1296097 | R_non-lesional_pre-dose | 339.97 | 61 |
GSM1296106 | S_non-lesional_pre-dose | 351.37 | 61 |
GSM1296102 | U_non-lesional_pre-dose | 219.04 | 53 |
GSM1296122 | V_non-lesional_pre-dose | 250.35 | 55 |
GSM1296089 | W_non-lesional_pre-dose | 216.83 | 53 |
GSM1296083 | X_non-lesional_pre-dose | 344.87 | 61 |
GSM1296116 | Y_non-lesional_pre-dose | 506.13 | 67 |
GSM1296085 | Z_non-lesional_pre-dose | 318.17 | 60 |